Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.7%

2 terminated/withdrawn out of 26 trials

Success Rate

91.3%

+4.8% vs industry average

Late-Stage Pipeline

27%

7 trials in Phase 3/4

Results Transparency

71%

15 of 21 completed trials have results

Key Signals

2 recruiting15 with results

Enrollment Performance

Analytics

Phase 2
15(60.0%)
Phase 3
7(28.0%)
N/A
2(8.0%)
Phase 1
1(4.0%)
25Total
Phase 2(15)
Phase 3(7)
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT07556393Phase 2Completed

Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis

Role: collaborator

NCT06254612Phase 2Recruiting

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Role: collaborator

NCT06602271Phase 3Recruiting

PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)

Role: collaborator

NCT05631626Phase 3Completed

Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.

Role: collaborator

NCT05686408Phase 2Completed

Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)

Role: collaborator

NCT05668754Phase 2Completed

Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH

Role: collaborator

NCT05796765Phase 2Terminated

Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis

Role: collaborator

NCT04290039Phase 1Completed

Sublingual vs IV Atropine Bioavailability Study

Role: collaborator

NCT04780984Phase 2Completed

Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT04627272Not ApplicableUnknown

AutoDx-DR Prospective Clinical Validation Study Protocol

Role: collaborator

NCT01652027Completed

Hemophilia Inhibitor Previously Untreated Patient Study

Role: collaborator

NCT03518125Phase 2Completed

BARDA Securing Anthrax Immunity For the Elderly

Role: collaborator

NCT03283319Phase 2Completed

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Role: collaborator

NCT02437383Phase 2Completed

Study of Orofacial Pain and PropRANOlol

Role: collaborator

NCT01660893Phase 3Terminated

Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth

Role: collaborator

NCT01304316Phase 2Completed

Dose-Escalation Safety and Pharmacokinetic Study of K305

Role: collaborator

NCT01710787Phase 3Completed

Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults

Role: collaborator

NCT01844830Phase 3Completed

Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric Patients

Role: collaborator

NCT01701505Phase 2Completed

Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects

Role: collaborator

NCT01807624Phase 2Completed

Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)

Role: collaborator